Discover 1,431 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,431
Routine vs On-demand ECMO for Lung Transplantation
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
for
Neoplasm Malignant
Location: New Brunswick NJ, Montreal, Baltimore MD, Ottawa,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07209111
Phase 2, Recruiting
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
for
Advanced Squamous Tumors
Location: Montreal, Toronto, Huntersville NC, Grand Rapids MI,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07241039
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ACT_for Alcohol Use Disorder and Depression
for
Depression - Major Depressive Disorder, Alcohol Use Disorder
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18 - 70
Code: NCT06620276
Recruiting
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions
for
Rheumatic Diseases, Inflammatory Arthritis,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 60+
Code: NCT07278609
Recruiting
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
for
Chronic Spontaneous Urticaria
Location: Quebec, The Bronx NY, Montreal, White Marsh MD, Ottawa,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07219615
Phase 2, Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
for
Intracerebral Hemorrhage
Location: Boston MA, Worcester MA, Stony Brook NY, Manhasset NY,
Sponsor: Joseph Broderick, MD
Sex: All
Age: 18 - 70+
Code: NCT07227246
Phase 3, Recruiting
Corticosteroid Against Saline Injections for Thumb Osteoarthritis (CASITOA)
for
Trapeziometacarpal Osteoarthritis
Location: Montreal
Sponsor: Université du Québec à Trois-Rivières
Sex: All
Age: 18+
Code: NCT06401317
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for
Parkinson's Disease
Location: Boston MA, New Haven CT, New York NY, Commack NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07174310
Phase 3, Recruiting
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
for
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Location: Quebec, New York NY, Saint-Charles-Borromee,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT07088926
Phase 2, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
for
Atrial Fibrillation
Location: Halifax, Sherbrooke, New York NY, Montreal, Camden NJ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07217067
Phase 2, Recruiting
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)